-
This fall, 2023, OGS has started to run an in-person Cayuse training session for the DAs on a monthly basis at the library training room. This small group hands-on training session is by invitation only. Please send your email request to OGS@einsteinmed.edu if you would like to participate.
-
ALL proposals (both federal and non-federal, including limited submissions and private foundations) must be reviewed and approved by OGS first in Cayuse before final submission to the funding agencies.
-
We strongly recommend submitting the applications to funding agencies at least 24 - 48 hours before the sponsor deadline date and time.
| | |
-
For eRA Commons user ID setup and verification, contact Cynthia Cardillo.
-
For JIT, FIS, NCE, Carryover and any help with ASSIST, contact Bethany Oates.
-
Melanie Bourghol coordinates proposal review in Cayuse SP and 424.
-
Select Dr. Indranil Basu as SO, BO or AOR as you find on the drop-down menu of the grant application portals. For DOD proposals, select Dr. Basu's name on both #5 and #19 in Cayuse SF424RR.
-
DMS Plan review requests may be made to Dr. Indranil Basu at least 3 days before the grant deadline. Make sure to address all 6 elements without any URLs or hyperlinks. The NIH and DOD DMS plan templates are available on request.
| |
Important links, forms and documents | |
|
Please click here for the slide deck of the OGS DA roundtable meeting on 9/5/23.
| |
Institutional Giving - Montefiore Einstein
Institutional Giving is part of the Office of Development and Alumni Affairs.
The list of Non-Governmental Funding Opportunities from the Office of Development’s Institutional Giving Team can be found here.
| | |
NOT-OD-23-161: NIH Application Instruction Updates Data Management and Sharing (DMS) Costs |
Effective for applications submitted for due dates on or after October 5, 2023, NIH will require applicants to specify estimated "DMS cost" details within the “Budget Justification” attachment of the R&R Budget Form or “Additional Narrative Justification” attachment of the PHS398 Modular Budget Form, pursuant to the instructions.
While the single cost line item is no longer required, "DMS costs" must be requested in the appropriate cost category, e.g. personnel, equipment, supplies, and other expenses, following the instructions for the R&R Budget Form or PHS 398 Modular Budget Form, as applicable. The link to the NIH announcement dated July 31, 2023 can be found here.
| | | |
National Institutes of Health | Division of Loan Repayment | The NIH Extramural Loan Repayment Program (LRP) application cycle is open from September 1 to November 16 this year. Participants in the NIH LRPs can receive up to $100,000 of qualified educational debt repayment with a two-year award. Please contact lrp@nih.gov for further details. | | |
Funding Opportunities - Department of Defense, Congressionally Directed Medical Research Programs: Transforming Health Care through Innovative and Impactful Research
| Please click read more to find the open funding opportunities. | | | |
NIH Common Data Elements (CDEs) and their Impact in Mental Health Research
If your grant is subject to NOT-MH-20-067 and/or NOT-MH-23-105, the NIMH Data Archive will prepopulate your Data Expected List with the appropriate NIH CDEs, along with the Research Subject & Pedigree data structure, in the Mandatory Data Structures section.
To further understand the value and purpose of CDEs, please explore the following publications:
If you want to alter the initial set of Data Structures added to your Data Expected List, please submit a ticket via email to the NDA Help Desk with a justification for the change.
Any requests not to collect data for any of the Mandatory CDEs should be sent to your Program Officer (PO) and/or to Gregory K. Farber, Ph.D. at farberg@mail.nih.gov for approval.
There is a new streamlined process for populating your Data Expected List. As part of these new guidelines, you can request data structure modifications directly from your NDA Collection. Once the data structure request is added to your Data Expected List, the NDA Data Curation team will be notified automatically - you don't need to email the NDA Help Desk.
Complete instructions on setting up your Data Expected List are available below. Data structure modifications and new data structure requests must follow the new procedures for the NDA Data Curation team to process your request.
| | |
Beginning October 23, 2023, NSF will require all Biosketch and Current and Pending documents to be created in SciENcv. Please refer to NSF’s FAQs on how to sign-in to SciENcv and prepare key personnel documents. Find some reference materials (links below) regarding the SciENcv information, helpful in populating NSF or NIH biosketches and/or NSF current and pending support as well: -
Click the video and slide deck links.
| |
|
|
Einstein 2030 Seed Fund
One new initiative funded by the recent $100 million anonymous gift to Einstein is the establishment of the Einstein 2030 Seed Fund. This fund will provide about $700,000/year to support studies by investigators that will enable them to generate the critical data and proof of concept studies that will serve as a pathway toward NIH funding.
While preference will be given to funding early or mid-career faculty, these seed funds are available to all Einstein principal investigators engaged in basic research to be utilized to support start-up efforts and new lines of research that show significant promise. The individual awards will range from $50,000-$150,000, with funding at the $150,000 level reserved for outstanding projects with well-justified budgets. Investigators can include funding for their effort on the project and these awards may be renewable based on strong evidence of significant progress.
The primary purpose of the Einstein 2030 Seed Fund is to support basic science research with potential translational applications and to bring discoveries to their next phase of evidence-based findings that will generate funding from NIH or other external sources. Review criteria used during the review process will be based on the reviewers’ assessment of the likelihood for the project to have a high impact and powerful influence on the research field(s) involved and strong potential for the proposed studies to generate results that will support the submission of a research project that will ultimately be funded by the NIH.
Eligibility: Applicants must be tenure-track faculty members holding the rank of Assistant Professor or higher.
For review of your application by Einstein’s Awards Committee, please send a single PDF file containing the following as an email attachment to indranil.basu@einsteinmed.edu by November 15, 2023:
1.Front page: (i) Title of the project; (ii) names of principal investigator and co-investigators, and their departmental affiliations; and (iii) abstract (up to 200 words). No institutional signatures are required.
2.Project description: Up to 3 pages (including specific aims, significance, innovation, and research design) plus one additional page for references. The project description should be single-spaced, 11-point font or larger, and margins should be at least 0.5 inches. Figure legends can use a smaller font.
3.Statement regarding future funding: On a separate page, applicants must include a short paragraph outlining how this seed funding will lead to a future NIH grant application.
4.Budget: Standard NIH format, with up to one page of budget justification.
5.Biographical Sketch: Standard NIH format, including Contribution to Science section.
6.Other Support: Information about applicant’s active and pending grant support, with amounts requested or approved, annual amounts, and duration of award.
| | |
Non-Federal Funding Opportunities | |
Career Awards for Medical Scientists - Burroughs Wellcome Fund |
Deadline: October 17, 2023
Amount: $700k/5 years
About: This award is for physician-scientists who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are not eligible. BWF anticipates making up to 12 awards including up to two awards to clinically trained psychiatrists who focus their research at the interface between psychiatry and neuroscience. Proposals that incorporate artificial intelligence and machine learning or climate change and human health are of particular interest.
Eligibility: Candidates must hold an MD, DO, DVM, VMD, or DDS; have completed clinical training (residency or fellowship) and be board eligible by award start date; may hold a junior faculty appointment (Lecturer, Instructor, Assistant Professor-non-tenure track, etc.); must be citizen or non-citizen permanent and temporary US resident legally qualified to work in the US. Additional requirements in the link below.
Links: BWF CAMS 2024 RFP and FAQs
Contact: Audrey McInerney (amcinerney@montefiore.org) for more information and/or assistance.
| | | |
Apply to the Academic Clinical Trials Program |
The Leukemia & Lymphoma Society (LLS) is pleased to announce the opening of the Academic Clinical Trials Program for 2023-2024.
The LLS ACT initiative is a clinical trial award program designed to develop cutting edge treatments that will have a meaningful impact on blood cancer patients. These awards will fund clinical trials, up to $1M USD over a period of up to three years. The LOI is due on October 25, 2023, 3 PM (EST). The ACT program guidelines and instructions can be found here.
LLS is seeking truly novel advances. The LLS ACT initiative is designed to develop experimental agents to address unmet medical needs, expand the use of approved therapeutics, and improve the use of novel treatment regimens in clinical settings.
Projects addressing follicular lymphoma may be selected for co-funding. This funding will be provided in a collaborative partnership between LLS and the Follicular Lymphoma Foundation. Please see the Cure FL Appendix in the ACT guidelines and instructions, which can be located at the lls.org link below.
A detailed description of the LLS Academic Clinical Trials Program and application instructions are available on the LLS Research Portal or the LLS site. All applications are to be submitted online through the LLS Research Portal. For additional questions regarding LLS research grant programs, eligibility, and application processes, please contact researchprograms@lls.org.
| | | |
National Glaucoma Research Request for Proposals |
New grants are available for research that begins in 2024, with an application deadline of October 31, 2023. BrightFocus provides research funds for U.S. domestic as well as international researchers to cover a wide range of investigator-initiated topics to better understand, treat, and prevent glaucoma, a leading cause of blindness. Please note that applicants to the NGR standard award program are encouraged to apply for funding to create tools that would benefit all investigators in the field, including animal models of disease, or cell lines.
Postdoctoral Fellowship (maximum award value $150,000, 2 years)
Standard Award (maximum award value $200,000, up to 2 years)
Visit BrightFocus/NGR-RFP for more information about the BrightFocus glaucoma grants, including how to apply.
| | | |
|
CRI Technology Impact Award – LOIs due November 15.
Provides seed funding to address the gap between technology development and clinical application of cancer immunotherapies. Academic faculty (assistant professor or higher rank) are invited to apply. Tech Impact Awards provide up to $200,000 over two years.
CRI Clinical Innovator – Protocol concepts due December 1.
Supports novel clinical studies that address areas of high unmet need in cancer and seek mechanistic insights into clinical response with the goal of predictive biomarker discovery. Up to $1M per trial.
CRI Clinic & Laboratory Integration Program (CLIP) - LOIs due December 1.
CLIP provides catalytic support for the translation of basic laboratory discoveries into novel therapies that can be tested in patients. CRI is pleased to announce an increase in the award amount for new CLIP grants. Awards now provide up to $300,000 over two years.
CRI Lloyd J. Old STAR Program – Applications due January 15.
Long-term funding for mid-career scientists pursuing high-risk, high-reward research at the forefront of discovery and innovation in cancer immunotherapy. CRI STARs are expected to be the future leaders in the field. STARs receive $1.25M over five years.
Click here to find all the CRI funding opportunities.
| | | | |